Market Size of Pigmented Lesion Treatment Industry
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 3.37 Billion |
| Market Size (2029) | USD 4.69 Billion |
| CAGR (2024 - 2029) | 6.80 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Pigmented Lesion Treatment Market Analysis
The Pigmented Lesion Treatment Market size is estimated at USD 3.37 billion in 2024, and is expected to reach USD 4.69 billion by 2029, growing at a CAGR of 6.80% during the forecast period (2024-2029).
The market for pigmented lesion treatments is witnessing robust growth, driven by several key factors. These include a rising prevalence of pigmentation lesions, heightened public awareness about skin treatments, the introduction of new products, and the establishment of specialized dermatology clinics.
An article from the August 2022 issue of Dermatological Review highlighted melasma as a prevalent form of acquired hyperpigmentation. It emphasized that this condition affected millions globally, with a notably higher incidence in women.
As research into pigmentation lesion diagnosis intensifies, the demand for treatment rises, subsequently fueling the need for specialized devices. This, in turn, could boost market growth.
In February 2022, GMV and the Biomedical Research Foundation of Madrid’s Hospital Universitario La Paz (FIBHULP) initiated the DALEM project. This project focuses on leveraging space technology to monitor pigmented skin lesions. Such collaborations, seen globally, offer enhanced monitoring capabilities, ultimately leading to more effective treatments.
Product innovation is also a significant driver. In October 2023, Rohrer Aesthetics, a prominent medical aesthetic device manufacturer, unveiled 'Symmetry.' This laser treatment, the first of its kind cleared by the FDA for hand rejuvenation, boasts SwiftScan Intelligent Technology. This technology ensures precise energy delivery, effectively addressing pigmented lesions, uneven pigmentation, brown spots, and other age-related skin concerns.
While the market is poised for growth, owing to the rising prevalence of pigmented lesions and innovative product launches, it is crucial to note that potential side effects from treatments could pose challenges to this growth trajectory.
Pigmented Lesion Treatment Industry Segmentation
As per the report's scope, pigmented lesions refer to brown or black skin spots, moles, age spots, and sun-damaged skin. Pigmented skin lesions are majorly melanocytic. However, non-melanocytic lesions can also be pigmented, specifically in dark-skinned individuals. Treatment of such disorders includes laser and energy-based devices and ultrasound devices.
The pigmented lesion treatment market is segmented by product type, end user, and geography. By product type, the market is sub-segmented into lasers and energy-based devices, RF devices, ultrasound devices, and other product types. By end user, the market is sub-segmented into dermatology clinics, beauty clinics, and other end users. By geography, the market is sub-segmented into North America, Europe, Asia-Pacific, the Middle East, Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD) for all the above segments.
| By Product Type | |
| Lasers and Energy Based Devices | |
| RF Devices | |
| Ultrasound Devices | |
| Other Product Types |
| By End User | |
| Dermatology Clinics | |
| Beauty Clinics | |
| Other End Users |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Pigmented Lesion Treatment Market Size Summary
The pigmented lesion treatment market is experiencing significant expansion, driven by an increasing prevalence of pigmentation disorders and heightened public awareness of skin treatments. The market is characterized by the introduction of innovative products and the establishment of specialized dermatology clinics, which are contributing to its robust growth. Advances in research and technology, such as the DALEM project leveraging space technology for skin lesion monitoring, are enhancing treatment capabilities. Product innovations, like Rohrer Aesthetics' FDA-cleared 'Symmetry' laser treatment, are also playing a crucial role in market dynamics. Despite the promising growth trajectory, potential side effects from treatments pose challenges that could impact market progression.
North America is at the forefront of the global pigmented lesion treatment market, supported by a strong healthcare infrastructure and the presence of key industry players. Regulatory approvals, such as those for Cynosure's PicoSure Pro and Candela Corporation's PicoWay laser system, are pivotal in driving market expansion in the region. Initiatives aimed at increasing awareness and screening for pigmented lesions further bolster market growth. The market is semi-consolidated, with major players like Alma Lasers Ltd, Cutera Inc., and Cynosure Inc. holding substantial shares. Recent advancements, such as Acclaro Medical's FDA clearance for its UltraClear laser and Reveal Lasers LLC's AlloraPro Laser Workstation, underscore the ongoing innovation and competitive landscape within the market.
Pigmented Lesion Treatment Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Geriatric Population
-
1.2.2 Increasing Prevalence of Pigmentation Disorders
-
-
1.3 Market Restraints
-
1.3.1 Side Effects Associated with Certain Treatments
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Buyers/Consumers
-
1.4.2 Bargaining Power of Suppliers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Product Type
-
2.1.1 Lasers and Energy Based Devices
-
2.1.2 RF Devices
-
2.1.3 Ultrasound Devices
-
2.1.4 Other Product Types
-
-
2.2 By End User
-
2.2.1 Dermatology Clinics
-
2.2.2 Beauty Clinics
-
2.2.3 Other End Users
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Pigmented Lesion Treatment Market Size FAQs
How big is the Pigmented Lesion Treatment Market?
The Pigmented Lesion Treatment Market size is expected to reach USD 3.37 billion in 2024 and grow at a CAGR of 6.80% to reach USD 4.69 billion by 2029.
What is the current Pigmented Lesion Treatment Market size?
In 2024, the Pigmented Lesion Treatment Market size is expected to reach USD 3.37 billion.
